Glenmark launches VWash Plus

Parent Category: Product

Posted in: Toiletries on Tuesday, 17 September 2013 06:18

Published on Tuesday, 17 September 2013 06:18

Written by Models n Trends

Hits: 2240

An expert intimate hygiene solution to empower today’s women with comfort and confidence

Glenmark Pharmaceuticals brings to you VWash Plus, a specially formulated Intimate Hygiene wash, designed to provide a woman’s intimate area the special care it needs. VWash Plus has Lactic Acid formula, which helps maintain the ideal pH balance of a woman’s delicate intimate area. It also contains anti-irritants like Tea Tree Oil and Sea Buckthorn Oil that help prevent dryness, itchiness and irritation.

The ideal pH balance for the intimate area ranges between pH 3.5 and 4.5. Any imbalance in pH could lead to discomfort. Most soaps are alkaline and have a pH value of 8-10. Even water has a pH value of 7. A daily soap and water cleansing routine, that most Indian women have been ignorantly following for generations, therefore, actually upsets the pH balance in a woman’s intimate area.

VWash Plus is also free of harmful chemicals like SLS and Parabens. Its special formulation helps in maintaining healthy vaginal flora. VWash Plus comes in an easy to use 100 ml bottle with a convenient flip top cap that prevents spilling. VWash Plus can be used anytime, and is easily available over the counter, without a prescription.

VWash Plus, for you daily comfort and confidence!

ABOUT GLENMARK PHARMACEUTICALS:

Glenmark Pharmaceuticals Ltd. (GPL) is a research-driven, global, integrated pharmaceutical company headquartered at Mumbai, India. It is ranked among the top 100 Pharma & Biotech companies of the world in terms of revenues. (SCRIP 100 Rankings published in the year 2012). Glenmark is a leading player in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity). Glenmark has several molecules in various stages of clinical development and is primarily focused in the areas of Inflammation [asthma/COPD, rheumatoid arthritis etc.] and Pain [neuropathic pain and inflammatory pain]. The company has a significant presence in branded generics markets across emerging economies including India. GPL along with its subsidiary has 14 manufacturing facilities in four countries and has six R&D centers spread across India, UK and Switzerland. Its subsidiary, Glenmark Generics Limited services the requirements of the US and Western Europe generics markets. The API business sells its products in over 80 countries, including the US, various countries in the EU, South America and India.